Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020572

VP Finance & Operations sold 440 shares at an average $0.37 ($161)

  • VP Finance & Operations acquired 1,516 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mitrano Richard J. · VP Finance & Operations

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-07 Sale : show line 1 in the form 10b5-1 −220 $0.36 $79 32,067 D
2023-07-07 Exercise or conversion : show line 2 in the form 10b5-1 +758 32,825 D
2023-07-10 Sale : show line 3 in the form 10b5-1 −220 $0.37 $81 32,605 D
2023-07-10 Exercise or conversion : show line 4 in the form 10b5-1 +758 33,363 D
Open-market sales · 440 sh · avg $0.37 · $161

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2023-07-07 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −758 758 22,726 D
2023-07-10 Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Unit −758 758 21,968 D
Loading xslF345X04/form4.xml…